Indication
Type 2 diabetes mellitus
Type 2 diabetes mellitus is a chronic metabolic disorder of the endocrine system characterized by persistent hyperglycemia due to peripheral insulin resistance and progressive pancreatic beta-cell secretory dysfunction. Read more about Type 2 diabetes mellitus
617 drugs 162 manufacturers
Drugs that treat it
Common Type 2 diabetes mellitus therapies.
METFORMIN HCL
STEGLUJAN (ertugliflozin pidolate/sitagliptin phosphate)
SEGLUROMET (ertugliflozin pidolate/metformin HCl)
INSULIN LISPRO
INSULIN LISPRO KWIKPEN U-100 (insulin lispro)
GLYBURIDE
GLYBURIDE MICRONIZED (glyburide,micronized)
REPAGLINIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonType 2 diabetes mellitus is a chronic metabolic disorder of the endocrine system characterized by persistent hyperglycemia due to peripheral insulin resistance and progressive pancreatic beta-cell secretory dysfunction.
Although predominantly diagnosed in adults, its prevalence has expanded across diverse age groups, frequently associated with obesity, systemic low-grade inflammation, and genetic predisposition.
Over time, sustained metabolic dysregulation causes vascular injury that leads to multi-organ complications, including microvascular pathology affecting the retinas, kidneys, and peripheral nerves, as well as accelerated macrovascular cardiovascular disease.
- nih.gov
Type 2 diabetes mellitus is a chronic metabolic disorder of the endocrine system characterized by persistent hyperglycemia due to peripheral insulin resistance and progressive pancreatic beta-cell secretory dysfunction
- nih.gov
Type 2 diabetes mellitus is a chronic metabolic disorder of the endocrine system characterized by persistent hyperglycemia due to peripheral insulin resistance and progressive pancreatic beta-cell secretory dysfunction Although predominantly diagnosed in adults, its prevalence has expanded across diverse age groups, frequently associated with obesity, systemic low-grade inflammation, and genetic predisposition
- nih.gov
Type 2 diabetes mellitus is a chronic metabolic disorder of the endocrine system characterized by persistent hyperglycemia due to peripheral insulin resistance and progressive pancreatic beta-cell secretory dysfunction Although predominantly diagnosed in adults, its prevalence has expanded across diverse age groups, frequently associated with obesity, systemic low-grade inflammation, and genetic predisposition
- nih.gov
Although predominantly diagnosed in adults, its prevalence has expanded across diverse age groups, frequently associated with obesity, systemic low-grade inflammation, and genetic predisposition Over time, sustained metabolic dysregulation causes vascular injury that leads to multi-organ complications, including microvascular pathology affecting the retinas, kidneys, and peripheral nerves, as well as accelerated macrovascular cardiovascular disease
- cdc.gov
Over time, sustained metabolic dysregulation causes vascular injury that leads to multi-organ complications, including microvascular pathology affecting the retinas, kidneys, and peripheral nerves, as well as accelerated macrovascular cardiovascular disease
- nih.gov
Over time, sustained metabolic dysregulation causes vascular injury that leads to multi-organ complications, including microvascular pathology affecting the retinas, kidneys, and peripheral nerves, as well as accelerated macrovascular cardiovascular disease
Personalize your experience
Follow Type 2 diabetes mellitus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.